We’re pleased to share that SalivIQ is now a portfolio company with the SWPDC - Southwest National Pediatric Device Innovation Consortium - an FDA-funded consortium aimed at advancing pediatric medical device innovation.Joining the
We’re pleased to share that SalivIQ is now a portfolio company with the SWPDC - Southwest National Pediatric Device Innovation Consortium - an FDA-funded consortium aimed at advancing pediatric medical device innovation.Joining the
We are thrilled to announce that Queen City Angels is the lead investor in SalivIQ’s Seed round!Over the past year, SalivIQ has made significant progress across our team, technology, and regulatory path as
We're excited to be featured in "Angel Network Pulse: The First 101" from The Diligent Observer - celebrating angel-backed innovation across 72 networks and 13 countries. Full report: https://lnkd.in/g3SJEBvg
We are excited to announce that Malachi Blundon, PhD is joining the SalivIQ team as Vice President of Research & Development!Malachi brings a unique blend of academic rigor and industry vision to SalivIQ.
We’re seeing clear signs of demand from both clinicians and parents as we move closer to making saliva testing for strep throat a reality. We now have clinical practices on our waiting list,
Join us at the ADLM Conference in Chicago July 28-30! We are excited to attend conference and meet in person with so many of SalivIQ’s amazing partners.
"I've been bitten, kicked, head butted and vomited on while doing swabs." - Pediatric nurse This is just one of the many quotes we’ve heard from providers about their challenging experiences with strep
Did you know that the gold standard diagnostic test for strep throat still involves growing bacteria on a petri dish? YES - in 2025, we're still relying on a method from the 1880s
Saliva: small sample 🤏 , big potential 💥 .In the SalivIQ lab, we're proving just how powerful this overlooked biofluid can be. Often dismissed as "just spit," saliva is a non-invasive, information-rich diagnostic
Another milestone achieved! We’ve just wrapped up our second FDA pre-submission, where we received valuable, actionable feedback that brings us one step closer to our goal – bringing SalivIQ™ Strep A to market.We’re